FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3201193 · Received July 2, 2013

Report

Report Number
1030489-2013-02870
Event Type
Injury
Date Received
July 2, 2013
Date of Event
February 7, 2013
Report Date
June 3, 2013
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P050053
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

LITERATURE ARTICLE CITATION: DESAI ET AL. USE OF RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2 FOR MANDIBLE RECONSTRUCTION. (B)(4). MEAN AGE, (B)(6). PATIENTS: 3 MALES, 3 FEMALES. IMPLANTED DATE: BETWEEN (B)(6) 2004 AND (B)(6) 2009. (B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Description of Event or Problem · 1

IT WAS REPORTED IN A LITERATURE PUBLICATION THAT A RETROSPECTIVE REVIEW WAS PERFORMED OF PATIENTS WHO HAD UNDERGONE REPAIR OF A MANDIBLE DEFECT USING RHBMP-2 WITH BETA-TRICALCIUM PHOSPHATE MATRIX OR A CADAVERIC BONE GRAFT. 6 PATIENTS UNDERWENT RECONSTRUCTION WITH THE USE OF RHBMP-2 FOR SEGMENTAL OR NEAR-COMPLETE RIM MANDIBULECTOMY DEFECTS. THE DEFECT LENGTHS RANGED FROM 5 TO 12 CM. THE NEAR-COMPLETE RIM MANDIBULECTOMY DEFECTS ALL HAD A REMAINING MANDIBLE HEIGHT OF LESS THAN 8 MM. FIVE PATIENTS HAD BENIGN NEOPLASMS, AND 1 PATIENT HAD CHRONIC MALUNION SECONDARY TO TRAUMA. ALL 6 PATIENTS EXPERIENCED MODERATE FACIAL SWELLING AFTER SURGERY THAT RESOLVED WITHIN 2 WEEKS. NO PATIENT REQUIRED ANY AIRWAY INTERVENTION FOR HIS OR HER POSTOPERATIVE SWELLING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
301531 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 00053 YR Other